7 Copper Ion Attenuated the Antiproliferative Activity of Di-2-pyridylhydrazone Dithiocarbamate Derivative; However, There Was a Lack of Correlation between ROS Generation and Antiproliferative Activity.

8 Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.

9 Metal-derived nanoparticles in tumor theranostics: Potential and limitations.

10 Application of Anti-Inflammatory Agents in Prostate Cancer

11 immune-checkpoint blockade and active immunotherapy for glioma

12 perspectives on reprogramming cancer-associated dendritic cells for antitumor therapies

13 tumor budding in upper gastrointestinal carcinomas

14 γδ t cells and tumor microenvironment: from immunosurveillance to tumor evasion

15 natural killer cell based therapies targeting cancer: possible strategies to gain and sustain anti-tumor activity

16 exploring small extracellular vesicles for precision medicine in prostate cancer

17 modulation of the intratumoral immune landscape by oncolytic herpes simplex virus virotherapy

18 the luxs/ai-2 quorum-sensing system of streptococcus pneumoniae is required to cause disease, and to regulate virulence- and metabolism-related genes in a rat model of middle ear infection

19 role of poly(ε-caprolactone) lipid-core nanocapsules on melanoma–neutrophil crosstalk

20 targeting pancreatic cancer cell plasticity: the latest in therapeutics

21 additive influence of extracellular ph, oxygen tension, and pressure on invasiveness and survival of human osteosarcoma cells

22 erratum: single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell–cell interaction

23 acquired natural killer cell dysfunction in the tumor microenvironment of classic hodgkin lymphoma

24 exosome-based cell-cell communication in the tumor microenvironment

25 nano-curcumin inhibits proliferation of esophageal adenocarcinoma cells and enhances the t cell mediated immune response

26 pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer

27 dendritic cells in oncolytic virus-based anti-cancer therapy

28 the tumor microenvironment and strategies to improve drug distribution

29 dying to be noticed: epigenetic regulation of immunogenic cell death for cancer immunotherapy

30 anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies – a review

31 the multifaceted mechanism of leptin signaling within tumor microenvironment in driving breast cancer growth and progression.

32 translational significance for tumor metastasis of tumor-associated macrophages and epithelial–mesenchymal transition

33 the tumor microenvironment: a pitch for multiple players

34 ykl-40 acts as an angiogenic factor to promote tumor angiogenesis

35 impact of semaphorin expression on prognostic characteristics in breast cancer

36 molecular and pathogenetic aspects of tumor budding in colorectal cancer

37 The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer

38 Dendritic cells in multiple myeloma: from immune evasion to therapeutic potential.

39 Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation.

40 Prognostic value of the triglyceride-glucose index in advanced gastric cancer: A call for further exploration.

41 Morpho-functional plasticity of tumour-associated macrophages: linking cell shape, ultrastructure, and immune regulation in cancer.

42 Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy.

43 Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment

44 Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy.

45 Effect of pH-Responsive Charge-Conversional Polymer Coating to Cationic Reduced Graphene Oxide Nanostructures for Tumor Microenvironment-Targeted Drug Delivery Systems.

46 Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.

47 Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer

48 CD8+CD73+ T cells in the tumor microenvironment of head and neck cancer patients are linked to diminished T cell infiltration and activation in tumor tissue.

49 Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment

50 checkpoint molecule pd-1-assisted cd8+ t lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

51 amino acid oncometabolism and immunomodulation of the tumor microenvironment in lung cancer

52 ohsv2 can target murine colon carcinoma by altering the immune status of the tumor microenvironment and inducing antitumor immunity

53 novel nanomaterials enable biomimetic models of the tumor microenvironment

54 effect of fractalkine, ip-10 and different signal pathway inhibitors on nk cells in the tumor microenvironment

55 smac mimetic-induced upregulation of ccl2/mcp-1 triggers migration and invasion of glioblastoma cells and influences the tumor microenvironment in a paracrine manner

56 the impact of the tumor microenvironment on the properties of glioma stem-like cells

57 oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison

58 the irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery

59 multitype network-guided target controllability in phenotypically characterized osteosarcoma: role of tumor microenvironment

60 macrophages in tumor microenvironments and the progression of tumors

61 tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing mmp-9 in the tumor microenvironment

62 tumor microenvironment varies under different tcm zheng models and correlates with treatment response to herbal medicine

63 modulation of the tumor microenvironment for cancer treatment: a biomaterials approach

64 extracellular vesicles as modulators of tumor microenvironment and disease progression in glioma

65 diffusion-weighted mri is insensitive to changes in the tumor microenvironment induced by antiangiogenic therapy

66 Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and Fatty Acid Biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence

67 Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

68 scCancer2: data-driven in-depth annotations of the tumor microenvironment at single-level resolution.

69 Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

70 Nanotechnology for Boosting Cancer Immunotherapy and Remodeling Tumor Microenvironment: The Horizons in Cancer Treatment.

71 Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment.

72 Intrapleural dual blockade of IL-6 and PD-L1 reprograms CAF dynamics and the tumor microenvironment in lung cancer-associated malignant pleural effusion.

Keyword Connections

Journals

Research Groups

Bibliographies